Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





N95 Face Masks Get Pathogen Killing Technology with Addition of New UVC Medical Device

By HospiMedica International staff writers
Posted on 24 Jun 2020
A new low-cost UVC medical device adds pathogen killing technology for N95 face masks that is effective on COVID-19.

N95 masks act as a barrier to help prevent the spread of pathogens in droplets from being exhaled and inhaled, but do not provide the capability to kill pathogens. More...
The technology developed by Brite-Strike Technologies Inc. (Duxbury, MA, USA) adds this critical component to N95 masks. The micro device can be installed in any N95 in seconds and can also be used in conjunction with hydrogen peroxide and a heat source to decontaminate a single user N95 mask in the field.

The company, which holds numerous patents related to LED light in visible, IR (infrared) and UV (ultraviolet) light as well as UV light for sterilization of air and water, has received FDA Pre-EAU approval to begin testing the device.

Related Links:
Brite-Strike Technologies Inc.


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.